3-溴吲哚-6-甲酸甲酯 | 860457-92-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 3-溴吲哚-6-甲酸甲酯
• 中文别名: 3-溴-1H-吲哚-6-羧酸甲酯
• 英文名称: methyl 3-bromo-1H-indole-6-carboxylate
• 英文别名: Methyl 3-bromoindole-6-carboxylate
• CAS: 860457-92-7
• 化学式: C₁₀H₈BrNO₂
• 分子量: 254.083
• InChiKey: YSCNGZSJIYDSOC-UHFFFAOYSA-N

物化性质

• 沸点：
  386.2±22.0 °C(Predicted)
• 密度：
  1.629

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  42.1
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 3-bromoindole-6-carboxylate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 3-bromoindole-6-carboxylate
CAS number: 860457-92-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H8BrNO2
Molecular weight: 254.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-溴吲哚-6-甲酸甲酯 在 Pd tetrakis 盐酸 、 4-二甲氨基吡啶 、 caesium carbonate 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 乙二醇二甲醚 、 水 、 乙酸乙酯 、 乙腈 为溶剂， 反应 86.0h， 生成 methyl 1-{2-[(2-{[4-(1-methylethyl)phenyl]amino}-2-oxoethyl)amino]ethyl}-3-phenyl-1H-indole-6-carboxylate
  参考文献：
  名称：

  [EN] CARBOXYL SUBSTITUTED INDOLES FOR USE AS PPAR ALPHA MODULATORS
  [FR] INDOLES À SUBSTITUTION CARBOXYLE DESTINÉS À ÊTRE UTILISÉS EN TANT QUE MODULATEURS DU PPAR-ALPHA

  摘要：

  根据本发明提供了式(I)的新化合物或其药用可接受的盐或溶剂，其中R1和R2中的一个是H，另一个是COOH。这些化合物可用作PPAR调节剂。

  公开号：

  WO2009147121A1
• 作为产物：
  描述：

  吲哚-6-甲酸甲酯 在 N-溴代丁二酰亚胺(NBS) 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 以80%的产率得到3-溴吲哚-6-甲酸甲酯
  参考文献：
  名称：

  β-吲哚氧基官能化天冬氨酸类似物作为兴奋性氨基酸转运蛋白 (EAAT) 的抑制剂

  摘要：

  兴奋性氨基酸转运蛋白 (EAAT) 介导主要兴奋性神经递质l-谷氨酸 (Glu) 的摄取。这些转运蛋白在调节中枢 Glu 水平方面的基本功能使它们成为广泛的神经退行性疾病和精神疾病的有趣治疗靶点。l -天冬氨酸 (Asp) 是另一种 EAAT 底物，已作为开发 EAAT 抑制剂的特殊支架。在这项研究中，我们设计并合成了第一个 β-吲哚氧基 Asp 类似物15a – d，目的是探测一个迄今为止尚未探索的与底物结合位点相邻的口袋。15a - d的药理特性在常规[ 3 H] -d- Asp 摄取测定中在hEAAT1-3 和rEAAT4 处表征。值得注意的是，噻吩类似物15B和对三氟甲基苯基模拟15D被发现被hEAAT1,2-宁愿抑制剂表现出的IC 50个在这两个转运值在高纳摩尔范围内（0.21-0.71μM）对IC 50个在低微摩尔值EAAT3,4 (1.6–8.9 μM) 的范围。总之，本文提

  DOI：

  10.1021/acsmedchemlett.0c00342

文献信息

• [EN] ASH1L INHIBITORS AND METHODS OF TREATMENT THEREWITH<br/>[FR] INHIBITEURS DE ASH1L ET MÉTHODES DE TRAITEMENT AU MOYEN DE CEUX-CI
  申请人：UNIV MICHIGAN REGENTS

  公开号：WO2017197240A1

  公开（公告）日：2017-11-16

  Provided herein are small molecule inhibitors of ASH1L activity and small molecules that facilitate ASH1L degradation and methods of use thereof for the treatment of disease, including acute leukemia, solid cancers and other diseases dependent on activity of ASH1L.

  本文提供了ASH1L活性的小分子抑制剂，促进ASH1L降解的小分子以及它们的使用方法，用于治疗疾病，包括急性白血病、实体肿瘤和其他依赖于ASH1L活性的疾病。
• Photocatalytic Oxidative Bromination of Electron-Rich Arenes and Heteroarenes by Anthraquinone
  作者：Daniel Petzold、Burkhard König

  DOI：10.1002/adsc.201701276

  日期：2018.2.15

  The estimated excited oxidation potential of sodium anthraquinone‐2‐sulfonate (SAS) increases from 1.8 V to about 2.3 V vs SCE by protonation with Brønsted acids. This increased photooxidation power of protonated anthraquinone was used for the regio‐selective oxidative bromination of electron rich (hetero)arenes and drugs in good yield. The mild reaction conditions are compatible with many functional

  通过布朗斯台德酸的质子化，蒽醌-2-磺酸钠（SAS）的估计激发氧化电势相对于SCE从1.8 V增加到约2.3V。质子化蒽醌提高的光氧化能力可用于富电子（杂）芳烃和药物的区域选择性氧化溴化，收率很好。温和的反应条件与许多官能团兼容，例如双键和三键，酮，酰胺和胺，羟基，羧酸和氨基甲酸酯。机理研究表明，芳烃的光氧化反应继之以亲核性溴化物添加是可能的途径。
• 钠通道阻滞剂
  申请人：山东轩竹医药科技有限公司

  公开号：CN111825595A

  公开（公告）日：2020-10-27

  本发明属于医药领域，具体涉及如式(I)所示的化合物、其药学上可接受的盐、其溶剂化合物或其异构体，含有所述化合物、其药学上可接受的盐、溶剂化合物或异构体的药物组合物，制备所述化合物、其药学上可接受的盐、溶剂化合物或异构体的方法，以及所述化合物、其药学上可接受的盐、溶剂化合物或异构体在制备药物中的应用，所述药物用于治疗和/或预防受试者的与Nav1.7通道相关的疾病。
• Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na_V1.7 Inhibitors for the Treatment of Pain
  作者：Guanglin Luo、Ling Chen、Amy Easton、Amy Newton、Clotilde Bourin、Eric Shields、Kathy Mosure、Matthew G. Soars、Ronald J. Knox、Michele Matchett、Rick L. Pieschl、Debra J. Post-Munson、Shuya Wang、James Herrington、John Graef、Kimberly Newberry、Digavalli V. Sivarao、Arun Senapati、Linda J. Bristow、Nicholas A. Meanwell、Lorin A. Thompson、Carolyn Dzierba

  DOI：10.1021/acs.jmedchem.8b01550

  日期：2019.1.24

  3-aryl-indazole derivatives were identified as potent and selective Nav1.7 inhibitors. Compound 29 was shown to be efficacious in the mouse formalin assay and also reduced complete Freund’s adjuvant (CFA)-induced thermal hyperalgesia and chronic constriction injury (CCI) induced cold allodynia and models of inflammatory and neuropathic pain, respectively, following intraperitoneal (IP) doses of 30 mg/kg

  3-芳基吲哚和3-芳基吲唑衍生物被确定为有效的和选择性的Na v 1.7抑制剂。化合物29在小鼠福尔马林测定中显示有效，并且在腹膜内（IP）后分别降低了完全弗氏佐剂（CFA）引起的热痛觉过敏和慢性收缩损伤（CCI）引起的冷痛觉过敏以及炎性和神经性疼痛模型剂量为30 mg / kg。观察到的功效可能与小鼠背根神经节暴露和Na V 1.7效价与29相关。
• [EN] PGDH INHIBITORS AND METHODS OF MAKING AND USING<br/>[FR] INHIBITEURS PGDH ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
  申请人：MYOFORTE THERAPEUTICS INC

  公开号：WO2021151014A1

  公开（公告）日：2021-07-29

  Disclosed herein are compounds that can inhibit 15-hydroxyprostaglandin dehydrogenase. Such compounds may be administered to subjects that may benefit from modulation of prostaglandin levels.

  本文披露了一些可以抑制15-羟基前列腺素脱氢酶的化合物。这些化合物可以用于给那些可能从前列腺素水平调节中受益的受试者。